A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis (Q47365588)
Jump to navigation
Jump to search
scientific article published in April 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis |
scientific article published in April 2004 |
Statements
1 reference
A multicenter, open-label, phase II study of the immunogenicity and safety of a new prefilled syringe (liquid) formulation of Avonex in patients with multiple sclerosis (English)
1 reference
Eric Eggenberger
1 reference
J Theodore Phillips
1 reference
George Rice
1 reference
Elliot Frohman
1 reference
Luc Vande Gaer
1 reference
Thomas Scott
1 reference
Judith Haas
1 reference
Mark S Freedman
1 reference
William Stuart
1 reference
Lawrence Jacobs
1 reference
Joel Oger
1 reference
Douglas Arnold
1 reference
T Jock Murray
1 reference
Mary DiBiase
1 reference
Vijay Jethwa
1 reference
Susan Goelz
1 reference
1 April 2004
1 reference
26
1 reference
4
1 reference
511-521
1 reference